Detalhe da pesquisa
1.
Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy.
Nat Immunol
; 25(4): 644-658, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38503922
2.
Therapy-induced APOBEC3A drives evolution of persistent cancer cells.
Nature
; 620(7973): 393-401, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37407818
3.
Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2.
Proc Natl Acad Sci U S A
; 120(3): e2211132120, 2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36623200
4.
Pralsetinib in patients with RET fusion-positive non-small-cell lung cancer: A plain language summary of the ARROW study.
Future Oncol
; 20(6): 297-306, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916501
5.
Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer.
N Engl J Med
; 383(9): 813-824, 2020 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32846060
6.
Lung cancer.
Lancet
; 398(10299): 535-554, 2021 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34273294
7.
Phase II Study of Cabozantinib in Patients With Bone Metastasis.
Oncologist
; 27(7): 600-606, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35524758
8.
Lymphocyte-activation gene 3 in non-small-cell lung carcinomas: correlations with clinicopathologic features and prognostic significance.
Mod Pathol
; 35(5): 615-624, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34880448
9.
Lung-RADS Category 3 and 4 Nodules on Lung Cancer Screening in Clinical Practice.
AJR Am J Roentgenol
; 219(1): 55-65, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35080453
10.
A combinatorial strategy for treating KRAS-mutant lung cancer.
Nature
; 534(7609): 647-51, 2016 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27338794
11.
Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study.
Lancet Oncol
; 22(12): 1740-1751, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34793719
12.
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study.
Lancet Oncol
; 22(7): 959-969, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34118197
13.
An early look at selective RET inhibitor resistance: new challenges and opportunities.
Br J Cancer
; 124(11): 1757-1758, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758332
14.
Temporal Trends in Inpatient Oncology Census Before and During the COVID-19 Pandemic and Rates of Nosocomial COVID-19 Among Patients with Cancer at a Large Academic Center.
Oncologist
; 26(8): e1427-e1433, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33932247
15.
Immune Checkpoint Inhibitors - The Need for Innovation.
N Engl J Med
; 388(16): 1529-1532, 2023 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37075146
16.
Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 21(6): 786-795, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32386568
17.
Performance status and end-of-life care among adults with non-small cell lung cancer receiving immune checkpoint inhibitors.
Cancer
; 126(10): 2288-2295, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32142165
18.
Cost-effectiveness of immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer.
Cancer
; 125(2): 278-289, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30343509
19.
Case 4-2021: A 70-Year-Old Woman with Dyspnea on Exertion and Abnormal Findings on Chest Imaging.
N Engl J Med
; 384(6): 563-574, 2021 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33567196
20.
Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F.
N Engl J Med
; 374(1): 54-61, 2016 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26698910